Role of bisphosphonates in metabolic bone diseases

This publication has 37 references indexed in Scilit:

• Bisphosphonates
  Drugs, 1991
• Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis
  New England Journal of Medicine, 1990
• Effects of Clodronate in Severe Hyperparathyroid Bone Disease in Chronic Renal Failure
  Nephron, 1990
• Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl)thiomethylene bisphosphonate, in the treatment of Paget's disease of bone
  Bone, 1988
• REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT
  The Lancet, 1987
• Efficacious Management with Aminobisphosphonate (APD) in Paget??s Disease of Bone
  Clinical Orthopaedics and Related Research, 1987
• Prevention of ectopic bone formation by local application of ethane-1-hydroxy-1,1-diphosphonate (EHDP): An experimental study in rabbits
  Journal of Orthopaedic Research, 1986
• Intravenous etidronate in the management of malignant hypercalcemia
  Archives of internal medicine (1960), 1985
• Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma
  Metabolic Bone Disease and Related Research, 1982
• Effect of a Diphosphonate on Para-Articular Ossification after total Hip Replacement
  Acta Orthopaedica, 1974